The average of price targets set by Wall Street analysts indicates a potential upside of 58.6% in Kiniksa Pharmaceuticals (KNSA). While the effectiveness of this highly sought-after metric is ...

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancers ...

Thanks to a loophole in the Federal Food, Drug, and Cosmetic Act of 1938, some of the “drugs” you can buy at pharmacies are ...

LUTTERAL: Yes. Dua Lipa – you're a Dua Lipa fan, I know that. PRIME MINISTER: I am indeed. And I hear from my Brisbane friends that travelling north there, to where the current venue is – PRIME ...

The broader consensus seems to be that India should capitalise on what could be the unintended consequences of Trump's tariff ...

2025 is finally upon us and the trends for healthcare marketers continue to evolve.

Shares of Jazz Pharmaceuticals (JAZZ) have gained 3% over the past four weeks to close the last trading session at $139.51, but there could still be a solid upside left in the stock if short-term ...

AppLovin (NASDAQ:APP) shares are down 14% so far this year, but some analysts are reiterating their bullish view on the stock ...

As the trend towards the international dispersion of certain value chain activities produces challenges, discover policies to meet these Tax transparency and international co-operation Enhanced ...